Oxford Health Insurance, Inc.
Mohr v. Oxford Health Insurance, Inc. et al.
United States District Court for Southern District of New York
Case No. 18-cv-1427
Keller Rohrback and co-counsel have filed cases against Oxford Health Insurance, Inc. (part of UnitedHealth Group Inc.) and their PBM OptumRx for a billing practice known as a “clawback.” UnitedHealth’s Oxford and OptumRx are overcharging participants for drugs. Via the retail pharmacy counter transaction, OptumRx asks patients to make co-payments that are higher than the real cost of the drug and then “claws back” the difference as profit for itself and its affiliates UnitedHealth and Oxford.
Because pharmacists are under a gag order that restricts pharmacists from telling participants they are being overcharged, most people have no idea this is happening to them. The clawbacks are a contributing factor to the high prices of health care in the United States, and also contribute to the yearly compensations of UnitedHealth companies CEOs. The CEO of United Healthcare alone received $14.5 million in 2015—which works out to $39,775 a day.
United Healthcare, Oxford, and OptumRx are taking advantage of people when they need help the most.
Complaint was recently filed on February 16, 2018, and is currently pending Motion to Dismiss briefing.